With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, introducing a new option for how patients can take medicines in a class of drugs that has revolutionized obesity treatment.